BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19171612)

  • 21. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
    Geier DA; Geier MR
    Pediatr Rehabil; 2003; 6(2):97-102. PubMed ID: 14534046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine.
    McMahon AW; Iskander JK; Haber P; Braun MM; Ball R
    Vaccine; 2008 Jan; 26(3):427-9. PubMed ID: 18093701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.
    Geier DA; Geier MR
    Med Sci Monit; 2005 Apr; 11(4):CR160-70. PubMed ID: 15795695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States.
    Geier DA; Geier MR
    Neuro Endocrinol Lett; 2006 Aug; 27(4):401-13. PubMed ID: 16807526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of duration of breastfeeding on neuropsychological development at 10 to 12 years of age in a cohort of healthy children.
    Tozzi AE; Bisiacchi P; Tarantino V; Chiarotti F; D'Elia L; De Mei B; Romano M; Gesualdo F; Salmaso S
    Dev Med Child Neurol; 2012 Sep; 54(9):843-8. PubMed ID: 22590982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mercury in vaccines and developmental problems: the latest research.
    Child Health Alert; 2007 Oct; 25():3. PubMed ID: 18273929
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lack of association between thimerosal-containing vaccines and autism].
    Mrozek-Budzyn D; Majewska R; Kiełtyka A; Augustyniak M
    Przegl Epidemiol; 2011; 65(3):491-5. PubMed ID: 22184954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
    Geier DA; Geier MR
    Med Sci Monit; 2004 Mar; 10(3):PI33-9. PubMed ID: 14976450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mercury in vaccines].
    Hessel L
    Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Making sense of epidemiological studies of young children exposed to thimerosal in vaccines.
    Dórea JG
    Clin Chim Acta; 2010 Nov; 411(21-22):1580-6. PubMed ID: 20638374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiomersal-containing vaccines - a review of the current state of knowledge.
    Gołoś A; Lutyńska A
    Przegl Epidemiol; 2015; 69(1):59-64, 157-61. PubMed ID: 25862449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early mercury exposure (with ethylmercury) could include 3-day olds: is that the case in China?
    Dórea JG
    Environ Res; 2008 Mar; 106(3):420; discussion 421-2. PubMed ID: 18221937
    [No Abstract]   [Full Text] [Related]  

  • 33. Thimerosal in vaccines--An interim report to clinicians. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Environmental Health.
    Pediatrics; 1999 Sep; 104(3 Pt 1):570-4. PubMed ID: 10469789
    [No Abstract]   [Full Text] [Related]  

  • 34. A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.
    Geier DA; Hooker BS; Kern JK; King PG; Sykes LK; Geier MR
    Int J Environ Res Public Health; 2014 Sep; 11(9):9156-70. PubMed ID: 25198681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thimerosal and vaccines--a cautionary tale.
    Offit PA
    N Engl J Med; 2007 Sep; 357(13):1278-9. PubMed ID: 17898096
    [No Abstract]   [Full Text] [Related]  

  • 36. An assessment of thimerosal use in childhood vaccines.
    Ball LK; Ball R; Pratt RD
    Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evidence for the safety of thiomersal in newborn and infant vaccines.
    Clements CJ
    Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling neurodevelopment outcomes and ethylmercury exposure from thimerosal-containing vaccines.
    Dórea JG; Marques RC
    Toxicol Sci; 2008 Jun; 103(2):414-5; author reply 416. PubMed ID: 18364366
    [No Abstract]   [Full Text] [Related]  

  • 39. A generalized reaction to thimerosal from an influenza vaccine.
    Lee-Wong M; Resnick D; Chong K
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):90-4. PubMed ID: 15702823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total mercury content in canine hair before and after administration of vaccines containing thiomersal.
    Sedlackova L; Kral T; Sevcikova M; Kruzikova K; Svobodova Z
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():90-4. PubMed ID: 24362099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.